FDA alert: Warning added to RSV vaccines for Guillain-Barré risk
The following is an FDA safety communication regarding updated warnings for RSV vaccines Abrysvo and Arexvy. FDA Safety Communication Purpose: To inform the public and healthcare providers that FDA has required and approved safety labeling changes to the Prescribing Information for […]
FDA alert: Warning added to RSV vaccines for Guillain-Barré risk Read More »
